Clinical outcomes of cemented distal femur replacements with all-polyethylene tibial components for oncologic indications

Figure 2 Competing risk analysis for cemented distal femoral replacement with all-polyethylene tibial component constructs for oncologic indications with all-cause revision (femoral or tibial component) and all-cause reoperation as the primary endpoints. One- and three-year cumulative incidences were 14.6% (95%CI 5.7%-27.4%) and 24.0% (95%CI 9.9%-41.4%), respectively, with all-cause revision as the endpoint. One- and three-year cumulative incidences were 26.1% (95%CI 14.2%-39.7%) and 47.2% (95%CI 27.5%-64.5%), respectively, with all-cause reoperation as the endpoint. DFR: Distal femoral replacement.